| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.083 | 0.6 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.081 | 0.6 |